mHACMb

Applied Biologics, LLC · Phase 2 active Small molecule

At a glance

Generic name	mHACMb
Also known as	40mg FloGraft (micronized human amnion chorion membrane)®, 100mg FloGraft (micronized human amnion chorion membrane)®
Sponsor	Applied Biologics, LLC
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

mHACMb CI brief — competitive landscape report
mHACMb updates RSS · CI watch RSS
Applied Biologics, LLC portfolio CI